Product References — Human Prorenin Native Recombinant

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Posted by Corey Marcath on

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Human Prorenin Native Recombinant from Innovative Research was used in the following study:   Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor Ye Liu, Atsuhiro Kanda, Di Wu, Erdal Tan Ishizuka, Satoru Kase, Kousuke Noda, Atsuhiro Ichihara, Susumu Ishida Molecular Therapy Nucleic Acids May 28, 2019 “…Age-related macular degeneration (AMD) is the leading cause of irreversible blindness worldwide. The wet (neovascular or exudative) type of AMD usually causes severe vision loss and is characterized by choroidal neovascularization (CNV), which extends from the choroid into the subretinal space and disrupts Bruch’s membrane and the...

Read more →

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Posted by Corey Marcath on

Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor

Human Prorenin Native Recombinant from Innovative Research was used in the following study:   Suppression of Choroidal Neovascularization and Fibrosis by a Novel RNAi Therapeutic Agent against (Pro)renin Receptor Ye Liu, Atsuhiro Kanda, Di Wu, Erdal Tan Ishizuka, Satoru Kase, Kousuke Noda, Atsuhiro Ichihara, and Susumu Ishida Molecular Therapy Nucleic Acids May 28, 2019 ”…Age-related macular degeneration (AMD) is the leading cause of irreversible blindness worldwide.1 The wet (neovascular or exudative) type of AMD usually causes severe vision loss and is characterized by choroidal neovascularization (CNV), which extends from the choroid into the subretinal space and disrupts Bruch’s membrane and...

Read more →